Literature DB >> 17559085

The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis.

Asish K Ghosh1, John Varga.   

Abstract

The transcriptional coactivator p300 is a ubiquitous nuclear phosphoprotein and transcriptional cofactor with intrinsic acetyltransferase activity. p300 controls the expression of numerous genes in cell-type and signal-specific manner, and plays a pivotal role in cellular proliferation, apoptosis, and embryogenesis. By catalyzing acetylation of histones and transcription factors, p300 plays a significant role in epigenetic regulation. Recent evidence suggests that abnormal p300 function is associated with deregulated target gene expression, and is implicated in inflammation, cancer, cardiac hypertrophy, and genetic disorders such as the Rubinstein-Taybi syndrome. The activity of p300 is regulated at multiple levels, including developmental stage-specific expression, post-translational modifications, subcellular localization, and cell-type and gene-specific interactions with transcription factors. Although p300 has been investigated extensively in epithelial and hematopoietic cells, its role in fibroblast biology and tissue repair has received little attention to date. Recent studies implicate p300 in the regulation of collagen synthesis by transforming growth factor-beta (TGF-beta). Both the acetyltransferase activity of p300 and its inducible interaction with Smad3 are essential for mediating TGF-beta-induced stimulation of collagen synthesis. As a signal integrator whose availability for intracellular interactions with transcription factors is strictly limiting, p300 mediates the antagonistic regulation of TGF-beta-induced collagen synthesis by IFN-gamma and TNF-alpha via intracellular competition for limiting amount of p300. Significantly, p300 is itself a direct transcriptional target of TGF-beta in normal fibroblasts, and its levels are significantly elevated in fibrotic lesions as well as in experimental models of fibrosis. The emerging appreciation of the importance of p300 in extracellular matrix (ECM) remodeling and fibrosis and novel insights concerning the regulation, mechanism of action, and significance of p300 in fibroblast biology are discussed in this minireview. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559085     DOI: 10.1002/jcp.21162

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  79 in total

Review 1.  Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.

Authors:  Swati Bhattacharyya; Minghua Wu; Feng Fang; Warren Tourtellotte; Carol Feghali-Bostwick; John Varga
Journal:  Matrix Biol       Date:  2011-04-13       Impact factor: 11.583

Review 2.  Molecular basis of CLL.

Authors:  Yuri Pekarsky; Nicola Zanesi; Carlo M Croce
Journal:  Semin Cancer Biol       Date:  2010-09-21       Impact factor: 15.707

3.  Gene-selective histone H3 acetylation in the absence of increase in global histone acetylation in liver of rats chronically fed alcohol.

Authors:  Pil-Hoon Park; Robert W Lim; Shivendra D Shukla
Journal:  Alcohol Alcohol       Date:  2012-02-02       Impact factor: 2.826

4.  Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor.

Authors:  Jonathan E Wilson; Gaurav Patel; Chirag Patel; Francois Brucelle; Annissa Huhn; Anna S Gardberg; Florence Poy; Nico Cantone; Archana Bommi-Reddy; Robert J Sims; Richard T Cummings; Julian R Levell
Journal:  ACS Med Chem Lett       Date:  2020-04-23       Impact factor: 4.345

Review 5.  Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer.

Authors:  Mohammadreza Hajjari; Atefeh Khoshnevisan; Young Kee Shin
Journal:  Tumour Biol       Date:  2014-09-30

Review 6.  Extracellular matrix roles during cardiac repair.

Authors:  Claude Jourdan-Lesaux; Jianhua Zhang; Merry L Lindsey
Journal:  Life Sci       Date:  2010-07-27       Impact factor: 5.037

7.  JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt.

Authors:  Xiunan Wang; Yan Yang; Dandan Ren; Yuanyuan Xia; Wenguang He; Qingsi Wu; Junling Zhang; Miao Liu; Yinan Du; Cuiping Ren; Bin Li; Jijia Shen; Yuxia Zhang
Journal:  Br J Pharmacol       Date:  2020-03-23       Impact factor: 8.739

8.  Catalytic mechanism of histone acetyltransferase p300: from the proton transfer to acetylation reaction.

Authors:  Xinlei Zhang; Sisheng Ouyang; Xiangqian Kong; Zhongjie Liang; Junyan Lu; Kongkai Zhu; Dan Zhao; Mingyue Zheng; Hualiang Jiang; Xin Liu; Ronen Marmorstein; Cheng Luo
Journal:  J Phys Chem B       Date:  2014-02-19       Impact factor: 2.991

9.  Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts.

Authors:  Laurence Goffin; Queralt Seguin-Estévez; Montserrat Alvarez; Walter Reith; Carlo Chizzolini
Journal:  Arthritis Res Ther       Date:  2010-04-29       Impact factor: 5.156

10.  NIR, an inhibitor of histone acetyltransferases, regulates transcription factor TAp63 and is controlled by the cell cycle.

Authors:  Kristina Heyne; Vivienne Willnecker; Julia Schneider; Marcel Conrad; Nina Raulf; Roland Schüle; Klaus Roemer
Journal:  Nucleic Acids Res       Date:  2010-01-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.